Cargando…

Protective effect of Panax quinquefolium 20(S)-protopanaxadiol saponins, isolated from Pana quinquefolium, on permanent focal cerebral ischemic injury in rats

Oxidative stress is significant in the pathogenesis of cerebral ischemia. Panax quinquefolium 20(S)-protopanaxadiol saponins (PQDS) have been demonstrated to exhibit a variety of biological effects in the cardiovascular system as a result of their antioxidant properties. However, little is known reg...

Descripción completa

Detalles Bibliográficos
Autores principales: XU, HUALI, YU, XIAOFENG, QU, SHAOCHUN, CHEN, YANGPING, WANG, ZHICAI, SUI, DAYUN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861457/
https://www.ncbi.nlm.nih.gov/pubmed/24348784
http://dx.doi.org/10.3892/etm.2013.1405
_version_ 1782295640534941696
author XU, HUALI
YU, XIAOFENG
QU, SHAOCHUN
CHEN, YANGPING
WANG, ZHICAI
SUI, DAYUN
author_facet XU, HUALI
YU, XIAOFENG
QU, SHAOCHUN
CHEN, YANGPING
WANG, ZHICAI
SUI, DAYUN
author_sort XU, HUALI
collection PubMed
description Oxidative stress is significant in the pathogenesis of cerebral ischemia. Panax quinquefolium 20(S)-protopanaxadiol saponins (PQDS) have been demonstrated to exhibit a variety of biological effects in the cardiovascular system as a result of their antioxidant properties. However, little is known regarding the effect of PQDS on cerebral ischemia. The purpose of this study was to investigate whether PQDS exhibited protective effects against cerebral ischemia. A model of cerebral ischemia was induced by middle cerebral artery occlusion (MCAO) in Sprague-Dawley rats. Adult male rats were randomly divided into five groups: Sham, MCAO and PQDS treatment groups at doses of 12.5, 25.0 and 50.0 mg/kg. The effects of PQDS on neurological deficits, cerebral infarct area, brain water content, and the malondialdehyde (MDA) and Ca(2+) levels and Na(+)-K(+)-ATPase and superoxide dismutase (SOD) activities in the brain tissue were analyzed, and the nitric oxide (NO) content and nitric oxide synthase (NOS) activity in the serum were evaluated. Moreover, the expression of Bcl-2 was analyzed using western blotting. Pretreatment with PQDS (25.0 and 50.0 mg/kg) significantly reduced the neurological deficit score, decreased the infarcted area and decreased the brain water content from 83.09 to 80.27% (P<0.05). In addition, PQDS pretreatment decreased the NOS activity and the NO levels in the serum compared with those in the MCAO group. Furthermore, pretreatment with PQDS (25.0 and 50.0 mg/kg) significantly increased the activities of SOD and Na(+)-K(+)-ATPase and decreased the levels of Ca(2+) and MDA in the brain tissue (P<0.05) compared with those in the MCAO group. Pretreatment with PQDS (25.0 and 50.0 mg/kg) also increased the protein expression level of Bcl-2 compared with that in the MCAO group. The histopathological results demonstrated the protective effect of PQDS on ischemic injury. The results indicated that PQDS has protective effects against ischemic injury in rats. The mechanism may be associated with the inhibition of oxidative stress and apoptosis.
format Online
Article
Text
id pubmed-3861457
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-38614572013-12-13 Protective effect of Panax quinquefolium 20(S)-protopanaxadiol saponins, isolated from Pana quinquefolium, on permanent focal cerebral ischemic injury in rats XU, HUALI YU, XIAOFENG QU, SHAOCHUN CHEN, YANGPING WANG, ZHICAI SUI, DAYUN Exp Ther Med Articles Oxidative stress is significant in the pathogenesis of cerebral ischemia. Panax quinquefolium 20(S)-protopanaxadiol saponins (PQDS) have been demonstrated to exhibit a variety of biological effects in the cardiovascular system as a result of their antioxidant properties. However, little is known regarding the effect of PQDS on cerebral ischemia. The purpose of this study was to investigate whether PQDS exhibited protective effects against cerebral ischemia. A model of cerebral ischemia was induced by middle cerebral artery occlusion (MCAO) in Sprague-Dawley rats. Adult male rats were randomly divided into five groups: Sham, MCAO and PQDS treatment groups at doses of 12.5, 25.0 and 50.0 mg/kg. The effects of PQDS on neurological deficits, cerebral infarct area, brain water content, and the malondialdehyde (MDA) and Ca(2+) levels and Na(+)-K(+)-ATPase and superoxide dismutase (SOD) activities in the brain tissue were analyzed, and the nitric oxide (NO) content and nitric oxide synthase (NOS) activity in the serum were evaluated. Moreover, the expression of Bcl-2 was analyzed using western blotting. Pretreatment with PQDS (25.0 and 50.0 mg/kg) significantly reduced the neurological deficit score, decreased the infarcted area and decreased the brain water content from 83.09 to 80.27% (P<0.05). In addition, PQDS pretreatment decreased the NOS activity and the NO levels in the serum compared with those in the MCAO group. Furthermore, pretreatment with PQDS (25.0 and 50.0 mg/kg) significantly increased the activities of SOD and Na(+)-K(+)-ATPase and decreased the levels of Ca(2+) and MDA in the brain tissue (P<0.05) compared with those in the MCAO group. Pretreatment with PQDS (25.0 and 50.0 mg/kg) also increased the protein expression level of Bcl-2 compared with that in the MCAO group. The histopathological results demonstrated the protective effect of PQDS on ischemic injury. The results indicated that PQDS has protective effects against ischemic injury in rats. The mechanism may be associated with the inhibition of oxidative stress and apoptosis. D.A. Spandidos 2014-01 2013-11-12 /pmc/articles/PMC3861457/ /pubmed/24348784 http://dx.doi.org/10.3892/etm.2013.1405 Text en Copyright © 2014, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Articles
XU, HUALI
YU, XIAOFENG
QU, SHAOCHUN
CHEN, YANGPING
WANG, ZHICAI
SUI, DAYUN
Protective effect of Panax quinquefolium 20(S)-protopanaxadiol saponins, isolated from Pana quinquefolium, on permanent focal cerebral ischemic injury in rats
title Protective effect of Panax quinquefolium 20(S)-protopanaxadiol saponins, isolated from Pana quinquefolium, on permanent focal cerebral ischemic injury in rats
title_full Protective effect of Panax quinquefolium 20(S)-protopanaxadiol saponins, isolated from Pana quinquefolium, on permanent focal cerebral ischemic injury in rats
title_fullStr Protective effect of Panax quinquefolium 20(S)-protopanaxadiol saponins, isolated from Pana quinquefolium, on permanent focal cerebral ischemic injury in rats
title_full_unstemmed Protective effect of Panax quinquefolium 20(S)-protopanaxadiol saponins, isolated from Pana quinquefolium, on permanent focal cerebral ischemic injury in rats
title_short Protective effect of Panax quinquefolium 20(S)-protopanaxadiol saponins, isolated from Pana quinquefolium, on permanent focal cerebral ischemic injury in rats
title_sort protective effect of panax quinquefolium 20(s)-protopanaxadiol saponins, isolated from pana quinquefolium, on permanent focal cerebral ischemic injury in rats
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861457/
https://www.ncbi.nlm.nih.gov/pubmed/24348784
http://dx.doi.org/10.3892/etm.2013.1405
work_keys_str_mv AT xuhuali protectiveeffectofpanaxquinquefolium20sprotopanaxadiolsaponinsisolatedfrompanaquinquefoliumonpermanentfocalcerebralischemicinjuryinrats
AT yuxiaofeng protectiveeffectofpanaxquinquefolium20sprotopanaxadiolsaponinsisolatedfrompanaquinquefoliumonpermanentfocalcerebralischemicinjuryinrats
AT qushaochun protectiveeffectofpanaxquinquefolium20sprotopanaxadiolsaponinsisolatedfrompanaquinquefoliumonpermanentfocalcerebralischemicinjuryinrats
AT chenyangping protectiveeffectofpanaxquinquefolium20sprotopanaxadiolsaponinsisolatedfrompanaquinquefoliumonpermanentfocalcerebralischemicinjuryinrats
AT wangzhicai protectiveeffectofpanaxquinquefolium20sprotopanaxadiolsaponinsisolatedfrompanaquinquefoliumonpermanentfocalcerebralischemicinjuryinrats
AT suidayun protectiveeffectofpanaxquinquefolium20sprotopanaxadiolsaponinsisolatedfrompanaquinquefoliumonpermanentfocalcerebralischemicinjuryinrats